Literature DB >> 11705919

Role of gamma interferon in the pathogenesis of severe schistosomiasis in interleukin-4-deficient mice.

A C La Flamme1, E A Patton, E J Pearce.   

Abstract

In the absence of interleukin-4 (IL-4), infection with Schistosoma mansoni leads to a severe fatal disease rather than the chronic survivable condition that occurs in wild-type (WT) mice. Because the sustained production of NO most closely correlates to weight loss and fatality in infected IL-4(-/-) mice and because gamma interferon (IFN-gamma) is an important inducer of inducible NO synthase, infected IL-4(-/-) mice were treated with anti-IFN-gamma antibodies to determine the role of IFN-gamma during schistosomiasis in WT and IL-4(-/-) animals. When IFN-gamma was neutralized, Th2 responses were enhanced and NO production was reduced in both WT and IL-4(-/-) mice. The decreased NO production correlated with a rescue of proliferation in splenocytes from infected IL-4(-/-) mice. Furthermore, the neutralization of IFN-gamma in vivo improved the gross appearance of the liver and led to a reduction in granuloma size in infected IL-4(-/-) but not WT mice. However, the neutralization of IFN-gamma in vivo did not affect the development of severe disease in infected IL-4(-/-) mice. These results suggest that while the increased production of IFN-gamma does lead to some of the pathology observed in infected IL-4(-/-) mice, it is not ultimately responsible for cachexia and death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705919      PMCID: PMC98833          DOI: 10.1128/IAI.69.12.7445-7452.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  The absence of IL-6 does not affect Th2 cell development in vivo, but does lead to impaired proliferation, IL-2 receptor expression, and B cell responses.

Authors:  A C La Flamme; E J Pearce
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.

Authors:  J K Mwatha; G Kimani; T Kamau; G G Mbugua; J H Ouma; J Mumo; A J Fulford; F M Jones; A E Butterworth; M B Roberts; D W Dunne
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

3.  Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice.

Authors:  I Mendel; A Katz; N Kozak; A Ben-Nun; M Revel
Journal:  Eur J Immunol       Date:  1998-05       Impact factor: 5.532

4.  Localization and regulation of IFN-gamma production within the granulomas of murine schistosomiasis in IL-4-deficient and control mice.

Authors:  E Rakasz; A M Blum; A Metwali; D E Elliott; J Li; Z K Ballas; K Qadir; R Lynch; J V Weinstock
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

5.  Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and gamma interferon-deficient mice chronically infected with Schistosoma mansoni.

Authors:  G Yap; A Cheever; P Caspar; D Jankovic; A Sher
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.

Authors:  D Jankovic; M C Kullberg; N Noben-Trauth; P Caspar; J M Ward; A W Cheever; W E Paul; A Sher
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

7.  Schistosoma mansoni in IL-4-deficient mice.

Authors:  E J Pearce; A Cheever; S Leonard; M Covalesky; R Fernandez-Botran; G Kohler; M Kopf
Journal:  Int Immunol       Date:  1996-04       Impact factor: 4.823

8.  Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  D C Hooper; S Spitsin; R B Kean; J M Champion; G M Dickson; I Chaudhry; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

9.  IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.

Authors:  H P Eugster; K Frei; M Kopf; H Lassmann; A Fontana
Journal:  Eur J Immunol       Date:  1998-07       Impact factor: 5.532

10.  IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.

Authors:  Y Okuda; S Sakoda; C C Bernard; H Fujimura; Y Saeki; T Kishimoto; T Yanagihara
Journal:  Int Immunol       Date:  1998-05       Impact factor: 4.823

View more
  4 in total

1.  Studies on parasitologic and haematologic activities of an enaminone derivative of 4-hydroxyquinolin-2(1H)-one against murine schistosomiasis mansoni.

Authors:  Amal M El-Shennawy; Amira H Mohamed; Mohamed Abass
Journal:  MedGenMed       Date:  2007-01-23

2.  Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model.

Authors:  Dilhan J Perera; Adam S Hassan; Yimei Jia; Alessandra Ricciardi; Michael J McCluskie; Risini D Weeratna; Momar Ndao
Journal:  Front Immunol       Date:  2020-11-16       Impact factor: 7.561

3.  Metabolic reprogramming of the myeloid lineage by Schistosoma mansoni infection persists independently of antigen exposure.

Authors:  Diana Cortes-Selva; Lisa Gibbs; J Alan Maschek; Marcia Nascimento; Tyler Van Ry; James E Cox; Eyal Amiel; Keke C Fairfax
Journal:  PLoS Pathog       Date:  2021-01-08       Impact factor: 6.823

4.  Dynamics of Host Immune Response Development During Schistosoma mansoni Infection.

Authors:  Alice H Costain; Alexander T Phythian-Adams; Stefano A P Colombo; Angela K Marley; Christian Owusu; Peter C Cook; Sheila L Brown; Lauren M Webb; Rachel J Lundie; Hermelijn H Smits; Matthew Berriman; Andrew S MacDonald
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.